{"disease":{"id":"idiopathic-interstitial-pneumonias","name":"idiopathic interstitial pneumonias"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04896138","title":"University of Virginia Natural History Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT03747627","title":"BPF Genetics of ILD Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":475,"lead_sponsor_name":"University of Dundee","has_results":false},{"nct_id":"NCT02138825","title":"Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":147,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT03142191","title":"A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":138,"lead_sponsor_name":"Celgene","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}